213 related articles for article (PubMed ID: 21816815)
1. Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors.
Dai Y; Chen S; Wang L; Pei XY; Funk VL; Kramer LB; Dent P; Grant S
J Biol Chem; 2011 Sep; 286(39):34036-50. PubMed ID: 21816815
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathway.
Yaseen A; Chen S; Hock S; Rosato R; Dent P; Dai Y; Grant S
Mol Pharmacol; 2012 Dec; 82(6):1030-41. PubMed ID: 22923501
[TBL] [Abstract][Full Text] [Related]
3. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.
Dai Y; Rahmani M; Dent P; Grant S
Mol Cell Biol; 2005 Jul; 25(13):5429-44. PubMed ID: 15964800
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors activate NF-kappaB in human leukemia cells through an ATM/NEMO-related pathway.
Rosato RR; Kolla SS; Hock SK; Almenara JA; Patel A; Amin S; Atadja P; Fisher PB; Dent P; Grant S
J Biol Chem; 2010 Mar; 285(13):10064-10077. PubMed ID: 20065354
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity.
Palkowitsch L; Leidner J; Ghosh S; Marienfeld RB
J Biol Chem; 2008 Jan; 283(1):76-86. PubMed ID: 17977820
[TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65.
Liu Y; Denlinger CE; Rundall BK; Smith PW; Jones DR
J Biol Chem; 2006 Oct; 281(42):31359-68. PubMed ID: 16926151
[TBL] [Abstract][Full Text] [Related]
7. Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol.
Gao N; Dai Y; Rahmani M; Dent P; Grant S
Mol Pharmacol; 2004 Oct; 66(4):956-63. PubMed ID: 15235103
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein.
Chen Y; Zhang J; Ge X; Du J; Deb DK; Li YC
J Biol Chem; 2013 Jul; 288(27):19450-8. PubMed ID: 23671281
[TBL] [Abstract][Full Text] [Related]
9. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha.
Horion J; Gloire G; El Mjiyad N; Quivy V; Vermeulen L; Vanden Berghe W; Haegeman G; Van Lint C; Piette J; Habraken Y
J Biol Chem; 2007 May; 282(21):15383-93. PubMed ID: 17409387
[TBL] [Abstract][Full Text] [Related]
11. Involvement of a novel Rac/RhoA guanosine triphosphatase-nuclear factor-kappaB inducing kinase signaling pathway mediating angiotensin II-induced RelA transactivation.
Choudhary S; Lu M; Cui R; Brasier AR
Mol Endocrinol; 2007 Sep; 21(9):2203-17. PubMed ID: 17595324
[TBL] [Abstract][Full Text] [Related]
12. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.
Hoberg JE; Popko AE; Ramsey CS; Mayo MW
Mol Cell Biol; 2006 Jan; 26(2):457-71. PubMed ID: 16382138
[TBL] [Abstract][Full Text] [Related]
13. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
Chen Lf ; Fischle W; Verdin E; Greene WC
Science; 2001 Aug; 293(5535):1653-7. PubMed ID: 11533489
[TBL] [Abstract][Full Text] [Related]
14. Dimethylcelecoxib induces an inhibitory complex consisting of HDAC1/NF-κB(p65)RelA leading to transcriptional downregulation of mPGES-1 and EGR1.
Deckmann K; Rörsch F; Geisslinger G; Grösch S
Cell Signal; 2012 Feb; 24(2):460-467. PubMed ID: 21983014
[TBL] [Abstract][Full Text] [Related]
15. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.
Jeong SJ; Pise-Masison CA; Radonovich MF; Park HU; Brady JN
J Biol Chem; 2005 Mar; 280(11):10326-32. PubMed ID: 15611068
[TBL] [Abstract][Full Text] [Related]
16. A distinct role of neutrophil lactoferrin in RelA/p65 phosphorylation on Ser536 by recruiting TNF receptor-associated factors to IkappaB kinase signaling complex.
Oh SM; Lee SH; Lee BJ; Pyo CW; Yoo NK; Lee SY; Kim J; Choi SY
J Immunol; 2007 Nov; 179(9):5686-92. PubMed ID: 17947640
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy.
Shulak L; Beljanski V; Chiang C; Dutta SM; Van Grevenynghe J; Belgnaoui SM; Nguyên TL; Di Lenardo T; Semmes OJ; Lin R; Hiscott J
J Virol; 2014 Mar; 88(5):2927-40. PubMed ID: 24371063
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65.
O'Mahony AM; Montano M; Van Beneden K; Chen LF; Greene WC
J Biol Chem; 2004 Apr; 279(18):18137-45. PubMed ID: 14963024
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Rela/p65 and endothelial cell inflammation by proline-rich tyrosine kinase 2.
Bijli KM; Fazal F; Rahman A
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):660-8. PubMed ID: 22842493
[TBL] [Abstract][Full Text] [Related]
20. Hyper-
Ma Z; Chalkley RJ; Vosseller K
J Biol Chem; 2017 Jun; 292(22):9150-9163. PubMed ID: 28416608
[No Abstract] [Full Text] [Related]
[Next] [New Search]